Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
186 studies found for:    "N-acetylglutamate synthase deficiency" OR "Amino Acid Metabolism, Inborn Errors"
Show Display Options
Rank Status Study
21 Recruiting Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
Condition: Metabolic Disease
Intervention:
22 Active, not recruiting Suitability of Nitisinone in Alkaptonuria 2
Condition: Alkaptonuria
Intervention: Drug: Nitisinone
23 Completed Dose Response Study of Nitisinone in Alkaptonuria
Condition: Alkaptonuria
Intervention: Drug: Nitisinone
24 Active, not recruiting Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria
Condition: Alkaptonuria
Intervention: Drug: Nitisinone
25 Completed
Has Results
Long-Term Study of Nitisinone to Treat Alkaptonuria
Condition: Alkaptonuria
Intervention: Drug: Nitisinone (NTBC)
26 Recruiting Study of Alkaptonuria
Condition: Alkaptonuria
Intervention:
27 Recruiting Short-term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia
Conditions: Propionic Acidemia, Type I and/or Type II;   Methylmalonic Acidemia;   Carbamoyl-Phosphate Synthase I Deficiency Disease;   Ornithine Carbamoyltransferase Deficiency
Interventions: Drug: Carbaglu;   Drug: Placebo;   Drug: Standard Care Treatment
28 Available Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism
Conditions: Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency;   Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2);   Mitochondrial Trifunctional Protein Deficiency;   Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency;   Glycogen Storage Disorders;   Pyruvate Carboxylase Deficiency Disease;   ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY of;   Barth Syndrome
Intervention: Drug: triheptanoin
29 Completed Biotin Status in Pregnancy
Condition: Biotin Deficiency
Intervention: Dietary Supplement: biotin
30 Completed
Has Results
Neurologic Injuries in Adults With Urea Cycle Disorders
Conditions: Brain Diseases, Metabolic, Inborn;   Urea Cycle Disorder;   Ornithine Transcarbamylase Deficiency
Intervention:
31 Completed Anaplerotic Therapy in Propionic Acidemia
Condition: Propionic Acidemia
Interventions: Drug: ornithine alpha ketoglutarate;   Drug: glutamine;   Drug: disodium citrate
32 Recruiting Effects of Oral Supplementation With Creatine on Systemic Microvascular Endothelial Function in Vegetarian Individuals
Conditions: Endothelial Dysfunction;   Hyperhomocysteinemia
Interventions: Dietary Supplement: monohydrate and micronized creatine;   Other: placebo
33 Completed
Has Results
Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children
Conditions: Hyperhomocysteinemia;   Obesity
Interventions: Drug: Folic Acid;   Drug: placebo
34 Completed The Effects of 8-week Choline, Betaine, and Folic Acid Supplementation on Plasma Homocysteine Concentration During Guanidinoacetic Acid Loading in Young Healthy Volunteers
Condition: Hyperhomocysteinemia
Interventions: Drug: TEST 1;   Drug: TEST 2;   Drug: TEST 3;   Drug: TEST 4
35 Completed Does B Vitamin Supplementation Decrease Homocysteine Concentrations in Newborns
Condition: Mild Hyperhomocysteinemia
Intervention: Drug: 5-formyltetrahydrofolate (10 mg/ml) (Pharmachemie bv)
36 Completed Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly
Condition: Hyperhomocysteinemia
Intervention: Dietary Supplement: Low-dose complex B-vitamins
37 Completed Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine
Condition: Hyperhomocysteinemia
Intervention: Dietary Supplement: S-adenosylmethionine
38 Completed Plasma Homocysteine Distribution in the United States
Conditions: Cardiovascular Diseases;   Heart Diseases;   Hyperhomocysteinemia
Intervention:
39 Completed 5-Methyltetrahydrofolate Survival and Inflammation in ESRD Patients
Conditions: Mortality;   Hyperhomocysteinemia;   Inflammation
Interventions: Drug: 5-MTHF (5-methyltetrahydrofolate);   Drug: folic acid
40 Enrolling by invitation Feasibility Study of the Intensive Systolic Blood Pressure Control
Conditions: Hypertension;   Hyperhomocysteinemia
Interventions: Drug: Standard BP control;   Drug: Moderate BP control;   Drug: Intensive BP control

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.